Jacobus P. Petzer

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

Jiang‐Fan Chen, Kui Xu, Jacobus P. Petzer et al. · PubMed · 2001 · 509 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Neuroprotection by Caffeine and A_2AAdenosine Receptor Inactivation in a Model of Parkinson's Disease

Jiang‐Fan Chen, Kui Xu, Jacobus P. Petzer et al. · Journal of Neuroscience · 2001 · 447 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson’s disease

Francesco Bibbiani, Justin D. Oh, Jacobus P. Petzer et al. · Experimental Neurology · 2003 · 204 citations

Medicine, Neuroscience, Pharmacology +14

8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism

Jiang‐Fan Chen, Salome Steyn, Roland G. W. Staal et al. · Journal of Biological Chemistry · 2002 · 117 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase

Anél Petzer, Brian H. Harvey, Gregers Wegener et al. · Toxicology and Applied Pharmacology · 2011 · 113 citations

Medicine, Medicinal Chemistry, Pharmacology +5